Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mecobalamin for prevention of complex regional pain syndrome type I after foot and ankle surgery
TCTR20220606006Phase 4Completed
- Sponsor
- Thammasat University
- Start
- Jun 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mecobalamin in Complex Regional Pain Syndrome Type 1 (CRPS-1), sponsored by Thammasat University. Started Jun 2022; status: completed.
02
Drugs
mecobalamin
03
Conditions
Complex Regional Pain Syndrome Type 1 (CRPS-1)
Beyond the preview
Go deeper on TCTR20220606006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220606006.